Vallon Pharmaceuticals
Vallon Pharmaceuticals (Nasdaq: VLON) was a clinical-stage biopharmaceutical company focused on the development and commercialization of novel abuse-deterrent medications for CNS disorders. In 2023, the company merged with GRI Bio (NASDAQ: GRI)
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
1 to 10
headcount range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Vallon Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Vallon Pharmaceuticals
4 distinct titles indexed · top 4 shown.
- 1acting chief medical officer
- 1drh
- 1finance manager
- 1selling clothsw
Sign up to unlock all 4 contacts at Vallon Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Vallon Pharmaceuticals
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.